In this study, ChIP-seq samples from leukaemia studies (i.e. acute myeloid leukaemia, T-cell acute lymphoblastic leukaemia and the MLL–AF9 translocation) were incorporated into the ‘TF association network’ together with other samples of normal cell types. This evidence concerns the gene KMT2A and leukemia.